Skip to main content
AKBA $0.42 +3.28%
AKBA logo
AKBA · Akebia Therapeutics, Inc.
Track AKBA — free
$0.42 +0.01 (+3.28%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19 2.75M Avg daily vol (3M) 8.17M
All webcasts

Earnings call · FY2019 Q4

Akebia Therapeutics, Inc. (AKBA) Q4 2019 Earnings Call

Concluded Mar 10, 2020
Mar 10, 2020
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $69.56M +16.2% YoY
Gross margin · derived Q4 45.2% -41.8 pp YoY
Net income -$94.48M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License Collaboration and Other Revenue$40.64M -23.4% YoY
Product$28.91M +323.7% YoY
Full-screen source Call document